phrykt

Nephros Inc (NEPH): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of NEPH were reported in the last 12 months. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Nephros

From the latest filings

Overall: more selling than buying. Famous investors mostly sold. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns NEPH

33 funds and institutions reported NEPH shares worth $19M at the end of Q2 2026, about 50% of the company. The largest holder is Wexford Capital LP with 33.8%.

Funds and institutions (13F) 50%Everyone else 50%

10 largest owners, by share of the company

Wexford Capital LP33.8%
Topline Capital Management, LLC5.0%
Vanguard Capital Management LLC1.9%
Morgan Stanley1.2%
Cornerstone Capital, Inc.1.2%
Bard Associates Inc1.1%
Renaissance Technologies LLC0.7%
Geode Capital Management, LLC0.7%
Mesirow Financial Investment Management, Inc.0.6%
HighTower Advisors, LLC0.6%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Wexford Capital LP3.60M33.83%$12.9MNo change
Topline Capital Management, LLC535,6985.03%$1.9M-8%
Vanguard Capital Management LLC198,6431.87%$709KNo change
Morgan Stanley128,9151.21%$460K+16%
Cornerstone Capital, Inc.128,7001.21%$459KNo change
Bard Associates Inc118,0031.11%$421K-3%
Renaissance Technologies LLC77,5040.73%$277K-22%
Geode Capital Management, LLC70,2630.66%$251K-4%
Mesirow Financial Investment Management, Inc.60,0000.56%$214K-50%
HighTower Advisors, LLC59,7100.56%$213KNo change
Navellier & Associates Inc53,4790.50%$191K+180%
Essex Investment Management Co LLC38,9270.37%$139K-0%
Vanguard Fiduciary Trust Co36,9010.35%$132KNo change
Blair William & Co36,2490.34%$129KNo change
Citadel Advisors LLC29,0440.27%$104K+39%
Dimensional Fund Advisors LP22,1640.21%$79.1K+7%
BlackRock, Inc.18,8220.18%$67.2KNew
De Lisle Partners LLP17,4000.16%$62.1K-30%
Northern Trust Corp16,7060.16%$59.6K+54%
State Street Corp15,6980.15%$56KNo change

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

No NEPH insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

NEPH short interest

Low short interest. 0.1% of NEPH shares are sold short: about 1 share in 912. Over the last 12 reports the number of shares short went down 44%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 11,913 NEPH shares were sold short, 0.1% of the shares outstanding, down 22.9% from the report before. At the average daily volume of 54,291 shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short, % of all shares

0.11%May 15Oct 300.47%

Days to cover

1.0May 15Oct 304.7

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202611,9130.11%-23%54,2911.0
Oct 15, 202615,4420.14%-39%54,3521.0
Sep 30, 202625,3020.23%-45%18,2721.4
Sep 15, 202646,4000.43%+13%22,5902.0
Aug 31, 202640,9670.38%-8%41,6021.0
Aug 14, 202644,7630.41%+19%26,9561.7
Jul 31, 202637,4930.35%+20%8,9724.2
Jul 15, 202631,3360.29%-1%9,4353.3
Jun 30, 202631,8120.30%+60%12,7922.5
Jun 15, 202619,9330.19%-21%11,6051.7
May 29, 202625,2950.24%+19%27,8171.0
May 15, 202621,1910.20%-29%40,6271.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Nephros company events

Nephros filed 7 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 5, 2026.

  1. Nov 5, 2026ResultsReleased financial results. Filing
  2. Oct 13, 2026AnnouncementOf this Current Report on Form 8-K is incorporated by reference into this Item 5.08. Filing
  3. Aug 6, 2026ResultsReleased financial results. Filing
  4. Jun 15, 2026AnnouncementShared information with investors. Filing
  5. May 7, 2026ResultsReleased financial results. Filing
  6. Mar 27, 2026AnnouncementShared information with investors. Filing
  7. Nov 26, 2025AgreementNephros, Inc. entered into a license and supply agreement with Medica S.p.A., an Italy-based medical product manufacturing company, for the marketing and sale of certain filtration products based upon Medica’s proprietary Medisulfone ultrafiltration technology in conjunction with the Company’s… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Nephros financials

Famous investors that hold NEPH

2 of the 50 well-known investors we track reported holding NEPH in their latest 13F filing. The largest position is Jim Simons's, worth $264K.

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 202671,100$264K0.0%-8%
Ken Griffin · Citadel AdvisorsQ3 202628,124$104K0.0%-3%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named NEPH in the last 120 days.

FiledHolderFormStake
Nov 16, 2026Topline Capital Management, LLC13G/A6.4%
Nov 16, 2026Topline Capital Management, LLC13G/A6.4%

Questions about Nephros Inc (NEPH) stock

Who owns the most NEPH stock?

The largest reported owner of Nephros Inc (NEPH) is Wexford Capital LP, with 33.8% of the company. In total, 33 funds and institutions reported holding NEPH at the end of Q2 2026, together about 50% of the shares. See the largest owners.

Are NEPH insiders buying or selling?

No NEPH insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in NEPH?

As of Oct 30, 2026, 11,913 NEPH shares were sold short, 0.1% of the shares outstanding, down 22.9% from the report before. At the average daily volume of 54,291 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Which famous investors hold NEPH?

2 of the 50 well-known investors we track reported NEPH in their latest 13F filing, including Jim Simons, Ken Griffin. The largest position is worth $264K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.